SAN DIEGO, March 14, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is investigating 10x Genomics, Inc. (NASDAQ:TXG) ("10x Genomics" or the "Company") for potential securities law violations. Shareholders who have incurred losses on their investment in the company are encouraged to contact the firm to learn about potentially recovering their losses. For more details on the investigation, visit https://www.johnsonfistel.com/investigations/10x-genomics
The investigation pertains to whether executives at the company misrepresented or failed to timely disclose material and adverse information ...
TXG) for Potential Securities Law Violations>Full story available on Benzinga.com